| English Alias: |
CPI-444;(S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine;Triazolo-pyramidine derivative;ciforadenant;CPI444;8KFO2187CP;CPI 444;V81444;Ciforadenant [USAN];Ciforadenant (USAN);V81444;(S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine;Ciforadenant [INN];GTPL10190;BCP20881;WHO 10767;Adenosine-A2A Receptor-Targeting Agent CPI-444;CIFORADENANT [WHO-DD];3H-1,2,3-Triazolo(4,5-d)pyrimidin-5-amine, 7-(5-methyl-2-furanyl)-3-((6-((((3S)-tetrahydro-3-furanyl)oxy)methyl)-2-pyridinyl)methyl)-;NSC-801812;D11547;BDBM50553404;V81444;Triazolo-pyramidine derivative;7-(5-methylfuran-2-yl)-3-[(6-{[(3S)-oxolan-3-yloxy]methyl}pyridin-2-yl)methyl]-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine;SCHEMBL536782;AS-75173;Ciforadenant (CPI-444)?;(S)-7-(5-Methylfuran-2-yl)-3-((6-((tetrahydrofuran-3-yloxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine;s6646;1202402-40-1;UNII-8KFO2187CP;V 81444;7-(5-methylfuran-2-yl)-3-((6-(((3S)-oxolan-3-yl)oxymethyl)pyridin-2-yl)methyl)triazolo(4,5-d)pyrimidin-5-amine;EX-A1716;7-(5-methylfuran-2-yl)-3-[[6-[[(3S)-oxolan-3-yl]oxymethyl]pyridin-2-yl]methyl]triazolo[4,5-d]pyrimidin-5-amine;AKOS037647889;ciforadenantum;CHEMBL4297184;7-(5-Methyl-2-furanyl)-3-[[6-[[[(3S)-tetrahydro-3-furanyl]oxy]methyl]-2-pyridinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine;CS-7627;HY-101978;V-81444;Ciforadenant [USAN:INN];(S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-5-amine;CPI-444; Triazolo-pyramidine Derivative;;7-(5-methylfuran-2-yl)-3-[(6-{[(3S)-oxolan-3-yloxy]methyl}pyridin-2-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine;NSC801812 |